
GITNUXSOFTWARE REVIEW
Healthcare & MedicineTop 9 Best Pharmacokinetic Software of 2026
A market-style roundup of pharmacokinetic software options, covering typical use cases and tradeoffs for teams choosing a workflow, including Julia.
How we ranked these tools
Vendors set the topic, but our editors set the inclusion criteria and the evaluation framework before research starts.
AI search agents find sources, extract figures with provenance, and aggregate written reviews. They also transcribe video reviews and podcasts.
Framework: Features 40% · Ease 30% · Value 30%
Gitnux may earn a commission through links on this page. This does not influence our reviews. Editorial policy
SAS Drug Development is the best overall pick for teams using SAS for regulated analytics that run population PK and simulations because its SAS-based pharmacometrics workflows strengthen end-to-end modeling, simulation, and diagnostics in clinical datasets, whereas NONMEM fits groups who need rigorous nonlinear mixed-effects control streams and diagnostics for complex PK/PD.
Editor’s top 3 picks
Three quick recommendations before you dive into the full comparison below — each one leads on a different dimension.
SAS Drug Development
Population pharmacokinetic modeling and simulation using SAS-based pharmacometrics workflows
Best for: Teams using SAS for regulated analytics that run population PK and simulations
NONMEM
Editor pickNONMEM control stream for nonlinear mixed-effects estimation with covariate and variability modeling
Best for: Population PK teams needing rigorous nonlinear mixed-effects modeling and diagnostics
Julia
Editor pickMultiple dispatch with just-in-time compilation for fast custom PK solver development
Best for: Teams building custom PK/PD models needing speed and modeling flexibility
Comparison Table
SAS Drug Development
enterprise analyticsSAS modeling and simulation capabilities support pharmacokinetic analysis workflows with statistical inference for clinical research datasets.
Population pharmacokinetic modeling and simulation using SAS-based pharmacometrics workflows
SAS Drug Development differentiates with an integrated modeling and simulation workflow that supports population pharmacokinetics and pharmacometrics studies within SAS’s analytics stack. Core capabilities include nonlinear mixed-effects modeling support, simulation and post-processing, and structured dataset handling designed for clinical drug development pipelines.
The toolset also emphasizes reproducible analysis via scripted data preparation, model fitting, and reporting artifacts. It fits teams that already rely on SAS for statistical governance, data transformation, and validated compute environments.
- +Strong population PK modeling workflows integrated with SAS data preparation
- +Simulation and diagnostics support model refinement and scenario planning
- +Reproducible scripted analyses align with regulated development documentation
- –Workflow depth can require SAS programming skill for efficient use
- –Less beginner-friendly than GUI-first pharmacometrics tools
- –Tight SAS ecosystem alignment can limit interoperability choices
Clinical pharmacometrics teams
Population PK model estimation on SAS data
Typical parameters with variability
SAS-centric biostatistics groups
Scripted model fitting and reporting
Reproducible analysis outputs
Show 1 more scenario
Modeling and simulation teams
Simulate dose regimens and post-process
Actionable simulation results
Generates simulated exposure profiles and uses structured post-processing for downstream PK evaluation.
Best for: Teams using SAS for regulated analytics that run population PK and simulations
NONMEM
population modelingNONMEM builds and validates population pharmacokinetic and pharmacodynamic models from clinical study data using nonlinear mixed effects methodology.
NONMEM control stream for nonlinear mixed-effects estimation with covariate and variability modeling
NONMEM stands out as a modeling workbench for nonlinear mixed-effects pharmacokinetics and pharmacodynamics with a long track record in regulated workflows. It supports nonlinear model estimation, complex residual error structures, covariate modeling, and advanced diagnostics for population PK.
The software integrates with external toolchains for data preparation and result review, and it is used to quantify inter-individual variability and parameter correlations. NONMEM’s strength is statistical rigor for heterogeneous patient and formulation variability using control stream driven model specifications.
- +Nonlinear mixed-effects estimation supports complex population PK and PD models
- +Covariate modeling estimates effects with structured variability and correlations
- +Robust diagnostics support model qualification workflows
- –Control-stream based modeling increases setup time for first-time users
- –Computational tuning and convergence troubleshooting require expert experience
- –Workflow integration depends on external scripting and downstream analysis tools
Pharmacometricians
Build population PK compartment models
Population PK model
PK/PD modelers
Link exposure to response in PD
Explainable exposure-response link
Show 2 more scenarios
Advanced PK/PD researchers
Run mechanistic PK/PD with ODEs
Dynamic mechanistic model
Represents complex biological and exposure-response processes using compartmental structures with ordinary differential equations.
Pharmacometrics statisticians
Test covariates for PK variability
Covariate-driven variability
Evaluates demographic and clinical factors as explanations for variability in PK or PD parameters.
Best for: Population PK teams needing rigorous nonlinear mixed-effects modeling and diagnostics
Julia
high-performanceJulia enables high-performance pharmacokinetic modeling and simulation workflows with scientific computing libraries and custom model code.
Multiple dispatch with just-in-time compilation for fast custom PK solver development
Julia is a high-performance scientific programming language used for building pharmacokinetic and pharmacodynamic models with near-C speeds. Core capabilities include fast numerical computing, first-class differential equation support, and seamless interoperability with optimized C and Fortran libraries.
Model development can span standalone scripts to production-grade solvers by combining automatic differentiation, extensive package ecosystem, and reproducible computation. For pharmacometrics workflows, it supports parameter estimation and uncertainty analysis by pairing with probabilistic and optimization tooling.
- +High performance ODE and SDE computations for PK model simulations
- +Automatic differentiation enables gradient-based parameter estimation
- +Large scientific package ecosystem supports calibration and inference workflows
- –Requires programming skills for model implementation and maintenance
- –PK-specific modeling abstractions are less turnkey than dedicated suites
- –Tooling and validation workflows depend heavily on custom project structure
Clinical pharmacometricians
Build ODE-based PK models rapidly
Faster model development cycles
Biostatistics and modeling teams
Run Bayesian parameter estimation pipelines
More stable uncertainty estimates
Show 2 more scenarios
Research software engineers
Integrate PK solvers with C libraries
Lower runtime and integration effort
Julia interoperates with optimized C and Fortran code for production-ready PK computations.
Translational modeling scientists
Perform sensitivity analysis for dosing
Clear drivers of exposure
Julia enables derivative-based sensitivity and uncertainty analyses for key dosing decision variables.
Best for: Teams building custom PK/PD models needing speed and modeling flexibility
Stan
Bayesian modelingStan supports Bayesian pharmacokinetic parameter estimation and posterior simulation using probabilistic programming for hierarchical models.
Hamiltonian Monte Carlo with automatic differentiation for Bayesian parameter inference
Stan is distinct for turning pharmacokinetic modeling into a probabilistic programming workflow built around Hamiltonian Monte Carlo. It supports Bayesian estimation of ordinary differential equation based PK models, including hierarchical population structures and custom likelihoods.
- +Bayesian PK via Stan language with fast gradient-based sampling
- +Flexible hierarchical models for population PK and covariate effects
- +Supports ODE likelihoods for dynamic PK models and simulation outputs
- +Posterior uncertainty drives rigorous parameter and prediction inference
- –Requires coding a model and interpreting sampling diagnostics
- –ODE models can be slow and sensitive to solver and parameterization
- –Tuning sampler settings can be necessary for stable convergence
- –Workflow lacks GUI-first fit, inspection, and model selection tooling
Bayesian pharmacometricians
Estimate hierarchical Bayesian PK parameters
Posterior parameter uncertainty
Mechanistic PK modelers
Fit ODE-based PK models in Stan
Mechanistic posterior predictions
Show 1 more scenario
Advanced model developers
Use custom likelihoods for PK data
Flexible likelihood modeling
Writes custom probability models to support nonstandard error and likelihood structures for PK fitting.
Best for: Teams building custom Bayesian PK models needing ODEs and rigorous uncertainty quantification
Certara Monolix alternative workflows
pharmacometricsCertara’s pharmacometrics software ecosystem supports pharmacokinetic and pharmacodynamic modeling, simulation, and reporting for drug development teams.
Monolix-compatible run workflow automation for estimation and simulation scenario execution
Certara Monolix alternative workflows focus on PK modeling execution through Monolix-compatible workflows that support simulation and parameter estimation runs in repeatable pipelines. Core capabilities center on nonlinear mixed-effects modeling workflows, including model building, estimation settings management, and simulation output handling across study iterations.
- +Supports repeatable PK modeling and simulation workflows across study iterations
- +Improves operational consistency by standardizing estimation and simulation configurations
- +Handles outputs for downstream analysis and reporting-focused PK work
- –Workflow depth can add complexity for teams without PK automation experience
- –Greater setup effort is needed than for single-session modeling usage
- –Customization for edge-case model steps may require additional engineering
Clinical pharmacometrics teams
Automate Monolix PK estimation runs
Faster reproducible parameter estimation
Translational science groups
Batch-run PK simulation scenarios
Consistent decision-ready simulation outputs
Show 2 more scenarios
Regulatory submission teams
Reproduce modeling results for reports
Reduced reporting rework
Track and reuse estimation and simulation configurations across iterations to support auditability.
Biostatistics operations
Manage study iterations in pipelines
Lower operational modeling overhead
Operationalize PK workflow automation so model runs and outputs are reused across versions.
Best for: PK teams operationalizing nonlinear mixed-effects modeling into repeatable run pipelines
gpkmodel
open-sourcegpkmodel provides code for pharmacokinetic model specification, fitting, and simulation workflows that can be integrated into analysis pipelines.
Scriptable compartmental PK modeling with simulation and fitting driven by model code
gpkmodel stands out as a GitHub-hosted pharmacokinetic modeling codebase that targets reproducible, script-driven workflows. It focuses on building and evaluating PK models such as compartmental structures, fitting them to concentration-time data, and producing simulated responses.
- +Code-first PK model specification supports version control and reproducible experiments
- +Compartmental modeling and simulation workflows fit common concentration-time analyses
- +Batch runs enable consistent refits and scenario testing across datasets
- –Workflow setup and debugging require strong modeling and software proficiency
- –Limited evidence of polished graphical diagnostics compared with dedicated PK suites
- –Model customization can be time-consuming for teams needing guided templates
Data scientists in version control
Reproducible PK modeling from scripts
Repeatable model results
PK modelers
Fit compartment models to concentration data
Estimated PK parameters
Show 1 more scenario
Simulation-driven analysts
Simulate responses from fitted PK models
Simulated response profiles
Generates simulated responses after fitting and applies model evaluation outputs for iterative refinement.
Best for: Research teams automating compartmental PK modeling in reproducible, code-driven pipelines
nlmixr
R mixed-effectsnlmixr supplies R-based nonlinear mixed effects pharmacokinetic and pharmacodynamic modeling tools focused on hierarchical model fitting and inference.
Stan-backed Bayesian inference for nonlinear mixed effects PK model estimation
nlmixr stands out as an open-source modeling tool that integrates nonlinear mixed effects modeling into an R workflow with a Stan backend. It supports PK model specification for population analysis, including common compartmental structures and covariate effects using estimated random effects.
- +Uses Stan-backed inference for nonlinear mixed effects PK models
- +Enables posterior predictive checks and simulation-driven model diagnostics
- +Keeps model code, data handling, and results in a single R pipeline
- +Rich support for covariates and random effects in population PK
- –Model syntax and debugging can be harder than GUI-based PK tools
- –Computational cost can be high for large datasets and complex random effects
- –Advanced diagnostics require familiarity with Bayesian concepts and Stan outputs
Data scientists in version control
Reproducible PK modeling from scripts
Repeatable model results
PK modelers
Fit compartment models to concentration data
Estimated PK parameters
Show 1 more scenario
Simulation-driven analysts
Simulate responses from fitted PK models
Simulated response profiles
Generates simulated responses after fitting and applies model evaluation outputs for iterative refinement.
Best for: Teams building reproducible Bayesian population PK models in R
Certara mRx
model-basedCertara mRx supports model-based simulations and population modeling workflows for pharmacometrics and pharmacokinetic decision-making.
Integrated model evaluation and simulation workflow for dose and exposure scenario planning
Certara mRx focuses on pharmacokinetic modeling workflows that connect analysis, simulation, and reporting for regulated decision-making. The solution supports NONMEM-ready modeling practices and integrates model building, evaluation, and scenario simulations for exposure and dose optimization. It is designed for teams that need traceable outputs and consistent PK evidence packages rather than standalone exploratory analytics.
- +Strong support for PK model building and scenario simulation workflows
- +Designed for regulated, traceable pharmacometrics deliverables
- +Integrates with NONMEM-centric modeling practices for established pipelines
- –Workflow setup and governance can feel heavy for smaller teams
- –Specialized pharmacometrics expertise is needed to use outputs correctly
- –Less suited for quick, lightweight exploratory PK analysis
Regulated modeling teams
Create traceable exposure simulations
Traceable PK evidence package
Pharmacokinetic modelers
Use NONMEM-aligned modeling practices
Consistent mRx workflows
Show 1 more scenario
Dose optimization groups
Compare dosing scenarios for exposure
Dose scenario ranking
Performs scenario-based simulations for exposure and dose optimization with structured reporting artifacts.
Best for: Pharmacometric teams producing regulated PK evidence packages using standard modeling pipelines
R
open-sourceR provides pharmacokinetic modeling and nonlinear mixed effects tooling through packages used for fitting, diagnostics, and simulation.
Integration with nonlinear mixed effects modeling packages for population PK estimation and simulation
R is distinct as a general-purpose statistical computing environment with a large ecosystem of pharmacokinetic packages. It supports nonlinear mixed effects modeling, nonlinear regression workflows, and extensive data import and transformation for PK datasets.
- +Rich PK ecosystem with nonlinear mixed effects and simulation workflows
- +Custom model building via user-defined functions and extensible model syntax
- +Strong graphics support for concentration-time views and diagnostic plots
- –Requires R scripting for reproducible end-to-end PK analysis workflows
- –Setup and package-specific learning curve can slow model implementation
- –No single unified PK interface for validation, reporting, and QA
Pharmacometric software teams
Run nonlinear mixed effects PK in R
Fitted PK parameter estimates
Custom PK model developers
Implement bespoke PK models and likelihoods
Custom model implementation
Show 1 more scenario
PK analysts
Simulate predictions and diagnostic plots
Diagnostic-ready visual outputs
Generates simulated predictions from fitted models and uses plotting for concentration-time and model diagnostics.
Best for: Teams needing flexible PK modeling, simulation, and analysis automation via code
Conclusion
After evaluating 9 pharmacokinetic software, SAS Drug Development stands out as our overall top pick — it scored highest across our combined criteria of features, ease of use, and value, which is why it sits at #1 in the rankings above.
Use the comparison table and detailed reviews above to validate the fit against your own requirements before committing to a tool.
Frequently Asked Questions About Pharmacokinetic Software
How do teams integrate pharmacokinetic model outputs with downstream reporting in Certara mRx versus NONMEM?
Which toolchains fit automation requirements for repeatable PK model run pipelines, especially when scenarios must be rerun consistently?
When a workflow requires provisioning and consistent access controls for multiple model authors, how do RBAC and audit logging typically show up?
What data migration steps are usually needed when moving concentration-time data and model artifacts from R workflows into NONMEM control stream processes?
How do extensibility and schema-level configuration differ between nlmixr and SAS Drug Development for PK/PD modeling pipelines?
What tradeoff appears when using Stan for population PK Bayesian estimation compared with NONMEM’s control stream workflow?
How does simulation throughput differ between Julia-based model development and tool suites that emphasize ready-made PK modeling interfaces?
Which workflow fits sparse sampling analysis needs when the team already uses NLME-style population modeling assumptions?
Where does data model alignment break most often when teams attempt to reuse model diagnostics across gpkmodel, R, and Stan?
Tools reviewed
Primary sources checked during evaluation.
Referenced in the comparison table and product reviews above.
How to Choose the Right Pharmacokinetic Software
Pharmacokinetic software options differ most in how far their integration and automation go when you build, run, and operationalize models. We recommend you compare integration depth and data model behavior, then verify update frequency and auditability during real workflows.
Workflow integration and API automation
Why it matters
Pharmacokinetic work often spans modeling, import/export, reporting, and re-runs. Workflow integration and API automation reduce manual handoffs when you iterate on models and results.
How to check
Ask to see a run that starts from an external dataset and returns outputs back into your environment using the documented API or scheduled automation. Confirm whether the API can trigger a batch, collect run logs, and write artifacts in a repeatable folder structure.
Data model mapping for studies and runs
Why it matters
Data model behavior determines whether the tool stays consistent across study versions, multiple cohorts, and repeated analyses. If mapping is unclear, you risk mismatched inputs and confusing outputs.
How to check
Bring a small sample study with at least two dataset versions (e.g., revised covariates). During the demo, trace how fields flow from import into outputs, and ask what happens when columns change or units differ.
Update frequency for modeling features
Why it matters
Update frequency matters because PK tooling evolves with better diagnostics, import support, and workflow changes. Frequent, controlled updates help avoid breaking changes mid-project.
How to check
Ask for the release cadence and a changelog showing modeling- and workflow-relevant updates. Confirm whether outputs remain comparable across versions by checking how the tool labels runs and stores version metadata.
Run provenance and audit log depth
Why it matters
Run provenance and audit log depth are critical when you must reproduce results for review. It also helps you debug why a re-run changed outputs.
How to check
Request a demo of re-running the same configuration after a minor change. Check whether the tool records inputs used, configuration parameters, environment/version details, and produces a traceable run history.
Diagnostics output coverage and export
Why it matters
Diagnostics output coverage shows whether reviewers can assess fit quality and assumptions without exporting everything into custom scripts. Export capability speeds up documentation and internal checks.
How to check
During the demo, generate diagnostics for a saved example and verify what plots/tables you can export (including underlying data, not only images). Ask how diagnostics behave when you change one modeling option.
Batch reproducibility for repeated studies
Why it matters
Batch reproducibility reduces time spent rebuilding project structure for each study or cohort. It also helps you compare outcomes across runs in a controlled way.
How to check
Ask them to run a small batch across two cohorts and then rerun after a configuration change. Verify whether batch jobs can be parameterized, whether outputs keep consistent naming, and whether prior artifacts remain accessible.
Red flags
- API automation exists, but manual steps are required between run and outputs.
- Run provenance is thin, so we can’t reproduce which inputs and settings produced results.
- Data model mapping breaks when dataset columns or units change between versions.
Fit by situation
- If we need to trigger modeling runs from our existing pipelines, prioritize workflow integration and API automation.
- If our team frequently revises study datasets and wants comparable outputs, prioritize data model mapping for studies and runs.
- If review and rework require strict traceability, prioritize run provenance and audit log depth.
Funding and competing interests
This study was co-funded by several of the vendors assessed in it. No single vendor funded it. Funders could propose the market studied.
They had no role in selecting vendors, setting or weighting criteria, analysing data or drawing conclusions, and they received the same factual-accuracy check as every other vendor assessed.
Market definition, inclusion rules and criteria weights were fixed by an editor before research began and did not change afterwards. Editorial process →
- Review · 2026 · Biotechnology PharmaceuticalsPharmacokinetic Modeling Software
- Review · 2026 · Healthcare MedicinePharmacy System Software
- Review · 2026 · Healthcare MedicinePharmaceuticals Software
- Review · 2026 · Healthcare MedicineHospital Pharmacy Software
- Review · 2026 · Healthcare MedicinePharmacy Workflow Software
Keep exploring
Comparing two specific tools?
Software Alternatives
See head-to-head software comparisons with feature breakdowns, pricing, and our recommendation for each use case.
Explore software alternatives→In this category
Healthcare & Medicine alternatives
See side-by-side comparisons of healthcare & medicine tools and pick the right one for your stack.
Compare healthcare & medicine tools→